Pharmacokinetics of Vancomycin among Patients with Chemotherapy-Associated Febrile Neutropenia: Which Would Be the Best Dosing to Obtain Appropriate Exposure?
Previous research has determined that the required doses for treating febrile neutropenia with vancomycin are higher than the doses used conventionally. These recommendations have been made considering pharmacotherapeutic goals based on minimum concentration (<inline-formula><math xmlns=&qu...
Main Authors: | Daniel Parra González, Jefferson Alejandro Pérez Mesa, Sonia Isabel Cuervo Maldonado, Jorge Augusto Díaz Rojas, Jorge Alberto Cortés, Edelberto Silva Gómez, Carlos Humberto Saavedra Trujillo, Julio Gómez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/11/1523 |
Similar Items
-
Optimizing Empiric Vancomycin Use in Febrile Neutropenia Patients
by: Nicole Tadros, et al.
Published: (2021-12-01) -
Altered Pharmacokinetics Parameters of Vancomycin in Patients with Hematological Malignancy with Febrile Neutropenia, a Bayesian Software Estimation
by: Abdullah M. Alzahrani, et al.
Published: (2023-05-01) -
Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
by: José C. Álvarez, et al.
Published: (2021-04-01) -
Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01) -
Secondary Infections in Cancer Patients with Febrile Neutropenia
by: Alpay Azap, et al.
Published: (2012-08-01)